Showing results (71-80 of 173) with videos related to

Sort By:
Pageof 18
Annals of the New York Academy of Sciences|November 30, 2006
Protection from type 1 diabetes by vitamin D receptor haplotypesElizabeth Ramos-Lopez, Thomas Jansen, Vytautas Ivaskevicius, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 16, 2007
CYP2R1-, CYP27B1- and CYP24-mRNA expression in German type 1 diabetes patientsElizabeth Ramos-Lopez, Patrick Brück, Thomas Jansen, et al.
International Journal of Cancer|August 9, 2008
Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cellsGerhard Held, Frank Neumann, Christine Sturm, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2013
EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumorsFrank Neumann, Dominic Kaddu-Mulindwa, Thomas Widmann, et al.
Annals of Hematology|January 10, 2025
Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experienceFelicitas Schulz, Claudia Roggenbuck, Andrea Kündgen, et al.
Leukemia & Lymphoma|December 11, 2007
Escalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myelomaRoland Fenk, Mark Michael, Fabian Zohren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximabJörg Thomas Bittenbring, Frank Neumann, Bettina Altmann, et al.
Cancer Immunity|December 18, 2003
Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2Claudia Wagner, Frank Neumann, Boris Kubuschok, et al.
Pageof 18